BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,503,632 | +39.3% | 50,900 | +36.5% | 0.02% | +50.0% |
| Q2 2023 | $3,233,164 | -52.6% | 37,300 | -46.9% | 0.01% | -60.0% |
| Q1 2023 | $6,826,248 | +53.8% | 70,200 | +63.6% | 0.02% | +150.0% |
| Q4 2022 | $4,439,721 | +131.7% | 42,900 | +89.8% | 0.01% | +150.0% |
| Q3 2022 | $1,916,000 | -31.8% | 22,600 | -33.3% | 0.00% | 0.0% |
| Q2 2022 | $2,809,000 | -57.5% | 33,900 | -60.5% | 0.00% | -42.9% |
| Q1 2022 | $6,615,000 | -33.1% | 85,800 | -23.4% | 0.01% | -12.5% |
| Q4 2021 | $9,895,000 | -32.6% | 112,000 | -41.1% | 0.01% | -50.0% |
| Q3 2021 | $14,685,000 | -12.0% | 190,000 | -5.0% | 0.02% | -20.0% |
| Q2 2021 | $16,688,000 | +47.2% | 200,000 | +33.2% | 0.02% | +17.6% |
| Q1 2021 | $11,334,000 | +24.5% | 150,100 | +44.6% | 0.02% | +6.2% |
| Q4 2020 | $9,102,000 | -49.2% | 103,800 | -56.0% | 0.02% | -71.4% |
| Q3 2020 | $17,932,000 | -19.1% | 235,700 | +31.1% | 0.06% | -45.1% |
| Q2 2020 | $22,177,000 | +300.7% | 179,800 | +174.5% | 0.10% | +126.7% |
| Q1 2020 | $5,535,000 | -18.8% | 65,500 | -18.7% | 0.04% | -2.2% |
| Q4 2019 | $6,815,000 | +113.8% | 80,600 | +70.4% | 0.05% | +76.9% |
| Q3 2019 | $3,188,000 | -28.4% | 47,300 | -9.0% | 0.03% | -35.0% |
| Q2 2019 | $4,454,000 | -4.3% | 52,000 | -0.8% | 0.04% | -23.1% |
| Q1 2019 | $4,655,000 | +17.0% | 52,400 | +12.2% | 0.05% | +52.9% |
| Q4 2018 | $3,977,000 | -3.7% | 46,700 | +9.6% | 0.03% | +3.0% |
| Q3 2018 | $4,131,000 | -42.0% | 42,600 | -43.7% | 0.03% | -45.9% |
| Q2 2018 | $7,122,000 | +144.7% | 75,600 | +110.6% | 0.06% | +110.3% |
| Q1 2018 | $2,910,000 | -64.7% | 35,900 | -61.2% | 0.03% | -50.0% |
| Q4 2017 | $8,248,000 | +82.7% | 92,500 | +90.7% | 0.06% | +41.5% |
| Q3 2017 | $4,514,000 | -0.4% | 48,500 | -2.8% | 0.04% | -12.8% |
| Q2 2017 | $4,532,000 | +10.8% | 49,900 | +7.1% | 0.05% | -2.1% |
| Q1 2017 | $4,091,000 | -19.3% | 46,600 | -23.9% | 0.05% | -2.0% |
| Q4 2016 | $5,070,000 | -56.4% | 61,200 | -51.3% | 0.05% | -61.1% |
| Q3 2016 | $11,630,000 | +72.8% | 125,700 | +45.3% | 0.13% | +57.5% |
| Q2 2016 | $6,730,000 | +25.3% | 86,500 | +32.9% | 0.08% | +5.3% |
| Q1 2016 | $5,369,000 | -37.3% | 65,100 | -20.3% | 0.08% | -24.8% |
| Q4 2015 | $8,559,000 | -10.0% | 81,700 | -9.5% | 0.10% | -22.9% |
| Q3 2015 | $9,510,000 | -40.0% | 90,300 | -22.1% | 0.13% | -41.0% |
| Q2 2015 | $15,853,000 | -11.6% | 115,900 | -19.5% | 0.22% | -21.3% |
| Q1 2015 | $17,933,000 | +7.1% | 143,900 | -22.3% | 0.28% | +11.5% |
| Q4 2014 | $16,751,000 | +46.1% | 185,300 | +16.6% | 0.25% | +42.9% |
| Q3 2014 | $11,466,000 | +64.6% | 158,900 | +41.9% | 0.18% | +65.4% |
| Q2 2014 | $6,968,000 | +18.1% | 112,000 | +29.5% | 0.11% | +8.1% |
| Q1 2014 | $5,900,000 | +3.5% | 86,500 | +6.7% | 0.10% | +15.1% |
| Q4 2013 | $5,699,000 | +81314.3% | 81,100 | +81000.0% | 0.09% | – |
| Q3 2013 | $7,000 | -97.8% | 100 | -98.2% | 0.00% | -100.0% |
| Q2 2013 | $312,000 | – | 5,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 240,400 | $19,922,000 | 0.01% |
| SIMPLEX TRADING, LLC | 43,900 | $3,637,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 33,900 | $2,809,000 | 0.00% |
| JPMORGAN CHASE & CO | 103,700 | $8,594,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |